NCT00799409 - The ABC Study: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral, and Cognitive Effects of CONCERTA on Older Children With ADHD

CSR Summary
NCT00799409
Primary Citation
Data Specification Not Available

Trial Information

Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaNervous SystemProduct ClassPsychoanalepticsPharmacological SubgroupPsychostimulants, Agents Used for ADHD and NootropicsChemical SubgroupCentrally Acting SympathomimeticsCondition StudiedAttention Deficit Hyperactivity Disorder

Sponsor Protocol NumberCONCERTA-ATT-4069Enrollment78Data PartnerJohnson & Johnson% Female29.5%Mean/Median Age (Years)10.1% White58%

Supporting Documentation

Collected Datasets Available
Protocol with Amendments Available
Statistical Analysis Plan Available
Clinical Study Report Available

Approved Data Requests Associated with this Trial

2024-0860 : Predicting Methylphenidate Response in Adult-ADHD (A-ADHD) Using Machine Learning Approaches
2020-4444 : Expectancy Effects as a Confounding Factor in ADHD Treatment Research
2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
2015-0592 : Detection of uninformative clinics during the trial of a new drug using statistical and machine learning techniques

You are not logged in.

Trial Information

Supporting Documentation

Approved Data Requests Associated with this Trial